Drug intelligence / Profile preview

varicella vaccine (Jiangsu gdk Biotechnology)

Development stage
Unknown
Lead developer
Jiangsu gdk Biotechnology
Modality
Vaccines & Immunotherapeutics
Administration
Subcutaneous
01

Overview

The varicella vaccine developed by Jiangsu gdk Biotechnology is a prophylactic agent designed to prevent chickenpox (varicella) caused by the varicella-zoster virus (VZV). It works by inducing a protective immune response, typically through the use of a live-attenuated virus, which stimulates the production of VZV-specific antibodies and cell-mediated immunity. This vaccine is part of the product portfolio of Jiangsu gdk Biotechnology, a Chinese vaccine manufacturer that also produces quadrivalent influenza vaccines. The vaccine is intended for use in children and susceptible adults to provide long-term protection against primary VZV infection and its associated complications.

Other names
varicella-zoster virus vaccinechickenpox vaccinevaricella vaccine-Jiangsu gdk Biotechnology-Varicella-zoster virus (VZV)-vaccine-Chickenpox (varicella)

Beyond the preview

Go deeper on varicella vaccine (Jiangsu gdk Biotechnology).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on varicella vaccine (Jiangsu gdk Biotechnology).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call